Background: A majority of renal tumors are incidentally detected and may therefore have been previously radiologically overlooked. Purpose: To investigate the frequency of previously radiologically overlooked renal cell carcinoma (RCC), identify tumor characteristics and imaging factors that contribute to misdiagnoses and to investigate its consequences. Material and Methods: All RCCs identified in a regional cancer registry over one year were retrieved (n ¼ 87). All preceding radiological examinations were re-analyzed for overlooked RCCs. Results: RCCs had been previously overlooked in 18 (21%) of the 87 patients (on 26 examinations: computed tomography [CT] ¼ 16, magnetic resonance imaging [MRI] ¼ 5, urography ¼ 3, ultrasound ¼ 2) or 18 (43%) of the 42 patients who had earlier radiological examinations. Overlooked RCCs were smaller than non-overlooked RCCs (median ¼ 23 mm; range ¼ 10-45 mm vs. 65 mm; range ¼ 13-207 mm) (P < 0.0001), more frequently located in upper pole, 50% vs. 26% (P ¼ 0.0836), and more frequently homogenous, 50% vs. 9% (P ¼ 0.0003). There was no difference in exophytic growth (60% vs. 60%) (P ¼ 0.74). Overlooked RCCs displayed poorer visualization on CT/MRI in all image planes (axial, coronal, sagittal) compared to non-overlooked tumors (P ¼ 0.004, P ¼ 0.001, P < 0.0001, respectively). Overlooked tumors had interval size progression of median 12 mm (range ¼ 0-65 mm) to clinical detection (median ¼ 1033 days). Conclusions: RCCs are frequently overlooked at imaging in the clinical routine. Overlooked tumors were smaller and displayed poorer visualization in all image planes compared to non-overlooked tumors. Substantial delay to clinical diagnosis and variable size progression was noted. Careful attention to the kidneys in multiple image planes seems warranted, irrespective of clinical indication.
Introduction
Although there is a considerable variation between different populations and regions, an increased incidence of renal cell carcinoma (RCC) has been observed in most Western countries in the last decade (1, 2) . This can partly be explained by the increased use of improved imaging methods, i.e. computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography, but also an increase in prevalence of etiological risk factors such as hypertension, obesity, and smoking (3) . In particular, incidental detection of renal tumors in patients examined with cross-sectional imaging for unrelated reasons (renal incidentalomas) has increased markedly. Recent statistics show that up to 60% of RCCs are detected incidentally (4) . Earlier detection may lead to treatment of smaller, asymptomatic RCCs with a lower tumor stage, potentially leading to better patient outcome (5) .
When renal or urinary tract cancer is clinically suspected, as with macroscopic hematuria, CT urography (CTU) is usually the method of choice (6) . Symptomatic RCCs, presenting with macroscopic hematuria, are usually large tumors which can be identified irrespective of choice of CTU imaging protocol (single bolus three-phase or a split-bolus protocol) (6) (7) (8) . The large proportion of incidentally detected RCCs, however, shows the importance of evaluating the kidneys on imaging examinations that anatomically include the kidneys, even when clinical focus is on unrelated disorders. It is largely unknown to what extent RCCs are overlooked at radiological examinations. Thus, diagnostic miss rate, including both symptomatic tumors and renal incidentalomas has, to our knowledge, previously not been studied. The aims of the present study were therefore to investigate the frequency of previously radiologically overlooked malignant renal tumors in patients with confirmed RCC, and to identify tumor characteristics and imaging factors, including study type, that may contribute to misdiagnoses, thereby providing data that potentially may improve patient care.
Material and Methods

Patients
Patients diagnosed with RCC in Sweden are registered in the National Swedish Kidney Cancer Registry (NSKCR), which has a 99% national coverage (4, 9) . In the present retrospective radiological re-evaluation study, patients aged > 18 years, diagnosed with RCC in the Western Region from 1 January to 31 December 2013 were identified in the NSKCR. Among these, 97 patients had been clinically handled (diagnosed and/or treated and/or followed) at the Sahlgrenska University Hospital, Gothenburg, Sweden, all with radiological image data available in the common, regional picture archiving system. The material thus comprised radiological examinations performed by various public and private healthcare providers. Residents outside the Western Region (n ¼ 8) and patients diagnosed with recurrent RCC (n ¼ 2) were excluded. The total number of patients included in the study was 87 (50 men, 37 women). Median age at the time of RCC diagnosis was 68 years (mean age ¼ 68 years; age range ¼ 28-93 years).
Blinded re-evaluation of imaging studies
The reports of all available radiological examinations from the included patients were scrutinized by an independent researcher, in order to identify the specific radiological examination where the RCC was diagnosed. All preceding radiological examinations, where the kidneys could potentially be visualized (CT, MRI, ultrasonography, urography), were identified and registered for re-analysis. Date of examination, institution, modality, indication, and the clinical question were documented.
The blinded re-evaluations of all preceding examinations were carried out by one of two senior abdominal radiologists with specific experience (>25 years) in the field of uroradiology. The images were re-examined, starting with the oldest examination of each patient. The reviewers were blinded, i.e. without access to the medical files or radiological reports and without knowledge of the occurrence, location, size, or characteristics of the RCC. In case the tumor had been clinically reported at first radiological examination (no previous examinations), the diagnostic examination was assessed in the same way. All radiological re-evaluations were performed on a dedicated image workstation (Centricity Radiology RA 600 V8.0, GE Healthcare).
Classification of pathological findings
Assessment with regard to renal tumor on each examination was made as follows: definitely normal/probably normal/probably abnormal/definitely abnormal/ not assessable. If a renal tumor was detected, its largest size (in three planes) was registered.
Each tumor was assigned a location: left/right kidney; upper/lower pole or central part; medial/ lateral; and anterior/posterior (10) . In the statistical analyses, a tumor with extension in two of the abovedescribed areas in the kidney on coronal images, the primary location was determined by the dominant part of the tumor. Tumors involving three or more areas were categorized as global.
The tumor visualization assessment was based on a subjective graded scale, assigning each tumor a score in each of the axial/coronal/sagittal views: 0 ¼ no visualization; 1 ¼ poor visualization; 2 ¼ intermediate visualization; 3 ¼ good visualization; and 4 ¼ very good visualization. In addition, the percentage of exophytic growth (proportion of tumor circumference reaching outside the normal renal outline) of each tumor was estimated (0-100%) as well as its heterogeneity (0 ¼ none, 1 ¼ slight, 2 ¼ moderate, 3 ¼ severe) and its attenuation/signal intensity in relation to surrounding parenchyma (iso-/hypo-/hyper attenuating/signaling) with or without i.v. contrast enhancement.
Unblinded re-evaluation of the imaging studies
After the blinded re-evaluation, images and reports of the radiological examination diagnosing the RCC were reviewed to gain knowledge of the confirmed final tumor location. An unblinded re-assessment of possible renal tumor on the preceding examinations was then made and compared to the blinded evaluation. The clinical radiological reports were scrutinized for any notation of potential mass in the kidneys for each examination before final diagnosis to determine if the tumor previously had been clinically overlooked by a miss in perception, or misinterpretation of a finding. An "overlooked" tumor was defined as a tumor not reported in the clinical radiology report, but detected at the retrospective radiological re-evaluation, or a misinterpretation of a finding mentioned in the clinical radiology report. Due to the difficulties in retrospective studies of ultrasonography examinations, a renal tumor could only be categorized as "overlooked" on renal ultrasonography when the tumor could be traced on a previous CT/MRI. A "non-overlooked" RCC is referred to as a tumor which could not be traced on earlier radiological examinations preceding clinical diagnosis.
Statistical methods
Comparisons between the groups "overlooked" versus "non-overlooked" tumors are as below.
Tumor size (mm) and exophytic growth (% of tumor circumference) were compared by Wilcoxon two-sample test. Proportions of tumors located in upper pole, central part, lower pole, and global, respectively, as well as proportions of tumor histopathology were compared by Chi-square test. Degrees of tumor heterogeneity (grade 0-3) and tumor visualization (grade 0-4) were compared by Mantel-Haenszel Chisquare test. Size comparison between tumors at CT and MRI were carried out by Wilcoxon two-sample test. Within the group of overlooked tumors, the proportions of tumors located in upper pole, central part, and lower pole, respectively, were compared by binomial exact test.
Data on overlooked RCCs, presented on a perpatient level (e.g. Table 1 ), were based on the examination when the tumor was first overlooked in the clinical routine.
Ethics
The study was approved by the Regional Ethical Review Board in Gothenburg. Informed consent was not required for this retrospective study.
Results
Frequency of overlooked tumors
Forty-two of the 87 included patients had earlier radiological examinations (range ¼ 1-5 examinations), visualizing the whole or parts of the kidneys, preceding the tumor-detecting examination. In the re-evaluation, clinically unreported renal tumors could be identified in 18 (21%) of the 87 included patients or 18 (43%) of the 42 patients with earlier radiological examinations preceding clinical detection. Adding all radiological examinations of these 18 patients, unrecognized RCCs could be identified in a total of 26 examinations, all categorized as "definitely abnormal" by the blinded reviewer ( Table 2 ). In one of the 18 patients, the tumor could be identified as "probably abnormal" at one One urography in the overlooked group was excluded from the size calculation because precise size measurement could not be performed (>60 mm). Estimation of heterogeneity could not be performed in two urographies in the patient group with overlooked tumors.
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Tumor location, characteristics, and visualization
There was no overall difference in tumor location between the group of overlooked and the group of non-overlooked tumors (P ¼ 0.16). However, overlooked tumors tended to be located in the upper pole more often than non-overlooked tumors (50% vs. 26%) (P ¼ 0.08), while location of tumors in the central part and lower pole were more evenly distributed (central part: 28% vs. 35%; lower pole: 16.5% vs. 16%) ( Table 1) . Global involvement was less common in the group of overlooked tumors (5.5% vs. 23%). In the group of overlooked tumors, upper pole tumor location (50%) was more common than central part (28%) or lower pole (16.5%) tumor location, but the differences were not statistically significant (P ¼ 0.424 and 0.146, respectively). There was no difference in the degree of exophytic tumor growth between the group of overlooked as compared to the group of non-overlooked tumors (median ¼ 60% vs. 60%; P ¼ 0.74) ( Table 1) . Overlooked RCCs were significantly more often homogenous than non-overlooked tumors (50% vs. 9%; P ¼ 0.0003). The overall degree of heterogeneity was significantly more pronounced in the nonoverlooked tumor group (P ¼ 0.0001). Only 12% of the overlooked tumors displayed a substantial heterogeneity (grade 2-3) compared to 77% of those not overlooked ( Table 1) .
The distribution of final histopathology differed between overlooked and non-overlooked tumors (P ¼ 0.0048) ( Table 1 ). There was a trend that clear cell RCC was less common in the overlooked group (67% vs. 86%), but the difference was not statistically significant (P > 0.08). In total, five renal tumors were clinically diagnosed but not histopathologically verified.
Tumor visualization and reasons for overlooking RCC
On a per-examination level, overlooked RCCs displayed significantly poorer visualization on CT and MRI in all image planes (axial, coronal, sagittal) compared to non-overlooked tumors (P ¼ 0.004, P ¼ 0.001, P < 0.0001, respectively) ( Table 4 ). On axial images, the visualization of overlooked RCCs was none to intermediate (0-2p) in 43%, compared to 22.5% of non-overlooked tumors. The corresponding figures for coronal images were 45% and 12%, and for sagittal images 70.5% and 25%, respectively.
The presumed cause of overlooking the tumors in the clinical routine was a miss in perception (tumor not reported) in 21 examinations and misinterpretation of a reported finding in five examinations. In examinations targeting the kidneys and the urinary tract, RCCs were overlooked due to a presumed miss in perception in 10 cases and misinterpretation in five cases ( Table 2) . In five cases, RCCs were overlooked on examinations using dedicated CTU protocols. In three CTU examinations (three patients) renal tumors were overlooked due to diagnostic misinterpretation (size ¼ 32 mm, 12 mm, 14 mm, respectively); these three tumors were clinically reported as benign cysts although significant contrast enhancement was present.
Consequences of overlooked tumors
The time interval, in patients where RCCs had been previously overlooked, between first identification at re-evaluation (categorized as "definitely abnormal" by Table 3 . Location, visualization and characteristics of renal tumors previously overlooked at radiological examinations in the clinical routine. 
Clear cell
The letter (a, p, x) assigned to the location of each tumor indicates anterior, posterior, or indeterminate location, respectively. Heterogeneity was subjectively assessed (0-3), from homogenous to highly heterogenous. Tumour visualization was subjectively graded as 0 (no visualization) to 4 (very good visualization).
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Acta Radiologica 60 (10) our reviewers) to clinical detection, was a median of 1133 days (mean ¼ 1258 days; range ¼ 2-3038 days) ( Table 2) . Once the overlooked tumors were finally detected, it was by way of incidental finding in 44% while the corresponding figure for non-overlooked cases was 51%.
Size progression per patient, calculated from the time of first identification in the re-evaluation to the time of clinical detection, was a median of 12 mm (mean ¼ 22 mm; range ¼ 0-65 mm) ( Fig. 1) . One patient was excluded from the calculation because the exact diameter of the tumor could not be measured (Patient 11, Table 2 ). At the time of clinical tumor detection, the presence of metastases was 28% in overlooked and 17% in non-overlooked cases.
Of patients with overlooked RCC 13/18 (72%) later underwent surgical treatment, compared to 59/69 (86%) of the patients with non-overlooked tumors: partial nephrectomy (39% vs. 26%); radical nephrectomy (11% vs. 51%); and radiofrequency ablation (22% vs. 9%) ( Table 2 ).
Discussion
In the present re-evaluation of radiological examinations in patients with confirmed RCC, previously overlooked tumors could be identified in 18 (21%) of 87 included patients. In fact, tumors had been overlooked in 43% (18/42 patients) of those who had radiological examinations preceding the clinically diagnosing examination. This caused a substantial diagnostic delay of median 3.1 years. Although there was a median interval tumor size progression of 12 mm (range ¼ 0-65 mm), the implications of this delay are unknown (increased risk of metastases, prognosis, etc.). Five patients with previously overlooked RCC had metastatic disease at Table 4 . Visualization (on a per-examination level) at re-evaluation of renal tumors, overlooked in the clinical routine, on CT and MRI examinations (n¼21), compared to non-overlooked tumors (n¼67).
Axial
Coronal Sagittal Values are presented as n (%). Ultrasonography and urography excluded (n ¼ 7). Coronal and sagittal imaging were not performed in one and two examinations, respectively, in the patient group with overlooked tumors. Sagittal imaging was not performed in four examinations in non-overlooked patients. Fig. 1 . Tumor size and interval growth in patients (n ¼ 18) with previously overlooked tumors. The last dot in each patient indicates the radiological examination clinically detecting the tumor. One patient (Patient 11), size > 60 mm at re-evaluation and 161 mm at clinical detection, was excluded because precise size measurement could not be performed on the urography examination.
clinical detection, but it is unknown if these existed already at the time of the preceding examinations. Nevertheless, as the prognosis of RCC is strongly associated with primary tumor size and the occurrence of distant metastases (4), there may have been an impact on outcome. Since a majority (72%) of the patients with overlooked RCC later underwent surgical intervention upon clinical detection, these overlooked tumors could not be discarded as clinically insignificant.
Our results show that the RCCs, overlooked in the clinical routine, were generally harder to detect than those clinically identified on first imaging (non-overlooked). There was no difference in exophytic growth pattern, but the overlooked tumors were smaller and less heterogenous. These tumor features, in combination with a "difficult" tumor location, the type of imaging modality and the clinical question asked are factors that may affect the detection of RCC. Our study showed that overlooked tumors displayed poorer visualization on axial, coronal, and sagittal images compared to non-overlooked ( Table 4 ). The tumors were generally easier to identify on coronal images. Our impression from the re-evaluation was that tumors in both patient groups, located in the cranial or caudal part of the upper or lower pole of the kidney respectively, commonly displayed poor visualization on axial images. Thus, the RCCs were often hard to distinguish in these locations on axial images, especially when being homogenous and isoattenuated to the surrounding parenchyma, while they were easily detected on coronal and sagittal images (Fig. 2) .
On 21 of the 26 occasions when tumors were previously overlooked, it was presumably caused by a miss in perception by the radiologist. However, this must not necessarily always be the case. In some cases, the kidneys were not mentioned in the radiological report. This may indicate that the kidneys had not been scrutinized, or that the kidneys were considered normal, or that a finding was made but considered unimportant in the specific clinical setting. In examinations where the radiologist mentioned the kidneys in the radiology report, clearly stating no abnormalities, potential explanations could be insufficient attention, or assessment limited to one image plane, e.g. the transaxial plane, when the tumor was better visualized in the coronal or sagittal plane. Speculating on the causes of misses in perception in examinations specifically targeting the kidneys and urinary tract (n ¼ 10), there are multiple potential factors. For instance, after a positive confirmation on a specific clinical question is made, e.g. urolithiasis, general coverage of other pathology may be made with less accuracy. This may be a reflection of psychological satisfaction (satisfaction of search). Another reason could be complicated pathology, e.g. multiple cysts, potentially causing discrete tumors to be overlooked (Fig. 3) . In five cases, RCCs were overlooked at CTU examinations (split bolus or threephase examinations), i.e. examinations specifically designed to identify renal pathology. At the retrospective review, the technical quality of the CTUs was considered adequate and could not explain why tumors were overlooked. Tumors were most commonly overlooked on CT (16 examinations), followed by MRI (five examinations). This probably reflects the higher number of CT examinations in clinical practice. Only two of the "overlooked" cases had been overlooked at ultrasonography. It is difficult to know to what extent renal tumors are missed or misdiagnosed on ultrasonography in clinical practice, as retrospective analysis of ultrasound images is not relevant as a test of diagnostic accuracy. The tumors overlooked on MRI were considerably larger than those overlooked on CT (median size ¼ 32 mm vs. 16.5 mm). All five MRI examinations targeted the lumbar spine, using a limited field of view which did not always include the entire kidneys. This, together with a specific clinical question focusing on the spine, may explain the larger size of overlooked tumors on MRI.
It is known, from other studies, that overlooked tumors in patients with different types of cancer are relatively common (11) (12) (13) . Most of these studies evaluated the ability of a specific targeted radiological method to detect cancer. One study with the purpose to evaluate the detection rate of renal cancer on unenhanced CT showed that 37% of the included patients with retrospectively detectable cancers were not clinically reported (14) .
Considering that 60% of RCCs are diagnosed incidentally (4), it is most important to evaluate the ability of different radiological examinations to diagnose RCC. Earlier diagnosis at an asymptomatic stage seems favorable for prognosis (15) . In general, miss rates of incidental findings are most likely higher than miss rates of abnormalities related to the specific clinical question asked. Thus, under-reporting of incidental radiological findings is a common phenomenon in clinical practice. A systematic re-evaluation of 3801 randomly selected CT examinations from a prospective cohort of >30,000 patients undergoing CT examinations, showed that 47% of adrenal lesions detected at re-evaluation were not mentioned in the original radiology report (16) . "Underreporting" of incidental findings is, however, not necessarily due to missed lesions. On the contrary, it may be a deliberate strategy to avoid "over-reporting" of lesions that are thought to be of minor or no clinical importance, considering the age, life expectancy, and co-morbidities of the individual patient. Selective reporting of, for example, small, indeterminate lesions in various organs may help in avoiding overdiagnosis of cancer and subsequent overtreatment of indolent tumors which may never reach clinical significance. However, RCC is unique in the high frequency of incidental detection and in that the vast majority (85%) of solid renal lesions constitute a malignant tumor (17) . Consciousness and knowledge of the high proportion of overlooked RCCs should therefore lead to careful assessment of the kidneys in multiple image planes. Double reading is also a way of securing diagnostic quality, implemented in some radiology departments. Another possibility that should be explored is the use of computer-aided diagnosis (CAD) (18, 19) .
In conclusion, RCCs are frequently overlooked at radiological imaging in the clinical routine. Overlooked tumors were generally smaller and somewhat less conspicuous than those that were not overlooked. Whether the prognosis was affected could not be determined, but it can be suspected as tumor size is an important prognostic factor. Thus, there is a Table 2 and Table 3 ) followed up after radical nephrectomy in the year of 2007, due to RCC in the right kidney. (a) A 10-mm renal mass was overlooked in the cranial part of the left kidney due to a miss in perception; (b) 25 months later, the renal mass (26 mm), fully visualized on coronal images on CT of the chest, was overlooked due to a miss in perception; (c) 16 months later, the renal mass (42 mm) was overlooked on abdominal CT due to miss in perception; (d) 12 months later, the renal mass (60 mm) was clinically detected, 1573 days after the first examination overlooking the tumor. The tumor was less apparent on transaxial images (not shown). potential for earlier diagnosis of RCC; considering that over half of RCCs are detected incidentally, careful attention to the kidneys in multiple image planes seems warranted, irrespective of the clinical indication.
